DMIIU (STOCKS)

    Drugs Made In America Acquisition II Corp. Unit

    Change: —
    Prev close: —
    Company Information
    Exchange
    XNAS
    Sector
    Industry
    CEO
    Asset Type
    stocks
    Website
    Fundamentals
    Market Cap
    Employees
    P/E (TTM)
    P/B (TTM)
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Revenues $0.00
    Operating Expenses $561.09K
    Operating Income/Loss -$561.09K
    Income/Loss From Continuing Operations After Tax $8.58M
    Income/Loss From Continuing Operations Before Tax $8.58M
    Net Income/Loss $8.58M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent $8.58M
    Net Income/Loss Available To Common Stockholders, Basic $8.58M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Assets $509.73M
    Current Assets $351.76K
    Prepaid Expenses $4.04K
    Other Current Assets $347.72K
    Noncurrent Assets $509.37M
    Liabilities $18.17M
    Current Liabilities $666.29K
    Accounts Payable $49.17K
    Other Current Liabilities $617.12K
    Noncurrent Liabilities $17.50M
    Equity -$17.81M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent -$17.81M
    Temporary Equity $509.37M
    Temporary Equity Attributable To Parent $509.37M
    Liabilities And Equity $509.73M
    Net Cash Flow From Operating Activities -$1.11M
    Net Cash Flow From Operating Activities, Continuing -$1.11M
    Net Cash Flow -$92.46K
    Net Cash Flow, Continuing -$92.46K
    Comprehensive Income/Loss $8.58M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent $8.58M
    Other Comprehensive Income/Loss $0.00